Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Vertex Pharmaceuticals Inc. buy TD Cowen

Start price
€451.85
23.07.24 / 50%
Target price
€460.55
23.07.25
Performance (%)
-10.92%
End price
€402.50
24.07.25
Summary
This prediction ended on 24.07.25 with a price of €402.50. The prediction for Vertex Pharmaceuticals Inc. disappointed with a performance of -10.92%. TD_Cowen has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Vertex Pharmaceuticals Inc. 0.763% 0.763% -14.391%
iShares Core DAX® -1.212% 1.925% 17.589%
iShares Nasdaq 100 -4.714% -1.810% 0.450%
iShares Nikkei 225® -2.976% -2.660% 10.156%
iShares S&P 500 -2.744% -0.448% 0.320%

Comments by TD_Cowen for this prediction

In the thread Trading Vertex Pharmaceuticals Inc.
Prediction Buy
Perf. (%) -10.92%
Target price 460.550
Change
Ends at 23.07.25

Die von TD_Cowen gewählte maximale Laufzeit wurde überschritten

In the thread Vertex Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) -10.92%
Target price 460.550
Change
Ends at 23.07.25

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at TD Cowen from $450.00 to $500.00. They now have a "buy" rating on the stock.
Ratings data for VRTX provided by MarketBeat